...
首页> 外文期刊>Analytical Sciences >A New Luciferase Reporter Gene Assay for the Detection of Androgenic and Antiandrogenic Effects Based on a Human Prostate Specific Antigen Promoter and PC3/AR Human Prostate Cancer Cells
【24h】

A New Luciferase Reporter Gene Assay for the Detection of Androgenic and Antiandrogenic Effects Based on a Human Prostate Specific Antigen Promoter and PC3/AR Human Prostate Cancer Cells

机译:基于人前列腺特异性抗原启动子和PC3 / AR人前列腺癌细胞的新型荧光素酶报告基因检测方法,用于检测雄激素和抗雄激素作用

获取原文
           

摘要

We developed a new mammalian cell-based luciferase reporter gene assay for androgenic and antiandrogenic activities of chemicals and environmental samples. Environmental samples usually have a complex matrix that may contain the constituents acting as androgen receptor (AR) agonists, AR antagonists or aryl hydrocarbon receptor (AhR) agonists. AhR agonists are known to elicit the antiandrogenic effect through cross-talk between AR and AhR signal transduction pathways. In this study, PC3/AR human prostate carcinoma cells were transiently transfected with a prostate-specific antigen (PSA) promoter-driven luciferase expression plasmid. The cells were treated with a test compound or an environmental sample for 24 h at 37°C and then measured for luciferase activity. The luciferase activity was induced by dihydrotestosterone (DHT) in a concentration-dependent manner in a concentration range from 10 fM to 1 nM. R1881, a synthetic androgen receptor agonist, induced luciferase activity and its inductive effects was additive to that of DHT. The luciferase activity was not induced by cortisol, a glucocorticoid, progesterone, a progestin, and 17β-estradiol, an estrogen in a concentration range of up to 1 μM. DHT-induced luciferase activity was reduced by bicalutamide and cyproterone acetate, AR antagonists, and also by benzo[a]pyrene, an aryl hydrocarbon receptor agonist, through AhR-mediated pathways. All of these findings indicate that the present assay system correctly responds to AR agonists, AR antagonists and AhR agonist and, therefore, it is a powerful tool for the sensitive and selective screening of chemicals and environmental samples for their androgenic and antiandrogenic activities. We developed the first assay system, in which the expression of luciferase was driven by the promoter of a prostate-specific antigen gene, a typical human androgen-regulated gene.
机译:我们开发了一种新的基于哺乳动物细胞的荧光素酶报告基因基因测定法,用于化学物质和环境样品的雄激素和抗雄激素活性。环境样品通常具有复杂的基质,其中可能包含充当雄激素受体(AR)激动剂,AR拮抗剂或芳烃受体(AhR)激动剂的成分。已知AhR激动剂通过AR和AhR信号转导途径之间的串扰引发抗雄激素作用。在这项研究中,用前列腺特异性抗原(PSA)启动子驱动的荧光素酶表达质粒瞬时转染PC3 / AR人前列腺癌细胞。在37℃下用测试化合物或环境样品处理细胞24小时,然后测量荧光素酶活性。二氢睾丸激素(DHT)以浓度依赖的方式在10 fM至1 nM的浓度范围内诱导萤光素酶活性。合成雄激素受体激动剂R1881诱导萤光素酶活性,其诱导作用与DHT相加。浓度不超过1μM的皮质醇,糖皮质激素,孕酮,孕激素和17β-雌二醇(雌激素)不会诱导萤光素酶活性。比卡鲁胺和醋酸环丙孕酮(AR拮抗剂),以及芳基烃受体激动剂苯并[a] re,通过AhR介导的途径降低了DHT诱导的荧光素酶活性。所有这些发现表明,本发明的测定系统对AR激动剂,AR拮抗剂和AhR激动剂具有正确的反应,因此,它是用于敏感和选择性筛选化学物质和环境样品的雄激素和抗雄激素活性的有力工具。我们开发了第一个测定系统,其中萤光素酶的表达由前列腺特异性抗原基因(一种典型的人类雄激素调节基因)的启动子驱动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号